Pharma giants see future of lower healthcare profits

Professor emeritus David Taylor (UCL School of Pharmacy) comments on the benefits and economic costs of pharmaceuticals, arguing cost effectiveness analyses should take a broader view of a drug's benefits.  Read: Financial Times